News

Isomorphic Labs Raises $5 Billion to Advance AI-Discovered Drug Candidates

Isomorphic Labs, an AI drug-discovery platform spun out of Google’s DeepMind in 2021, has raised $5 billion in a Series C funding round.

The company is using the capital to advance drug candidates into clinical trials, marking a significant step in its effort to apply artificial intelligence across the drug-development process. The scale of the round also highlights the level of investment directed toward AI-based drug discovery.

Sources